OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.320
-0.030 (-2.22%)
At close: Aug 6, 2026, 4:00 PM EDT
1.320
0.00 (0.00%)
Pre-market: Aug 7, 2026, 7:35 AM EDT
OPKO Health Revenue
OPKO Health had revenue of $163.58M in the quarter ending June 30, 2026, with 4.32% growth. This brings the company's revenue in the last twelve months to $439.45M, down -33.82% year-over-year. In the year 2025, OPKO Health had annual revenue of $606.90M, down -14.90%.
Revenue (ttm)
$439.45M
Revenue Growth
-33.82%
P/S Ratio
1.68
Revenue / Employee
$258,416
Employees
2,275
Market Cap
985.15M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 606.90M | -106.24M | -14.90% |
| Dec 31, 2024 | 713.14M | -150.35M | -17.41% |
| Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
| Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
| Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
| Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
| Dec 31, 2019 | 901.94M | -88.33M | -8.92% |
| Dec 31, 2018 | 990.27M | 24.26M | 2.51% |
| Dec 31, 2017 | 966.01M | -151.49M | -13.56% |
| Dec 31, 2016 | 1.12B | 625.76M | 127.25% |
| Dec 31, 2015 | 491.74M | 400.61M | 439.63% |
| Dec 31, 2014 | 91.13M | -5.41M | -5.60% |
| Dec 31, 2013 | 96.53M | 49.49M | 105.19% |
| Dec 31, 2012 | 47.04M | 19.07M | 68.14% |
| Dec 31, 2011 | 27.98M | -515.00K | -1.81% |
| Dec 31, 2010 | 28.49M | 24.08M | 544.95% |
| Dec 31, 2009 | 4.42M | -5.02M | -53.20% |
| Dec 31, 2008 | 9.44M | 8.59M | 1,014.52% |
| Dec 31, 2007 | 847.00K | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Myriad Genetics | 806.60M |
| NeoGenomics | 766.30M |
| Veracyte | 561.90M |
| CareDx | 458.09M |
| GeneDx Holdings | 454.43M |
| Castle Biosciences | 357.28M |
| Fulgent Genetics | 323.93M |
| Adaptive Biotechnologies | 308.08M |
OPK News
- 4 days ago - Cocrystal Pharma announces $5M investment from Opko Health - TheFly
- 4 days ago - Cocrystal Pharma announces $5M private placement with Opko Health - TheFly
- 10 days ago - Opko Health sees Q3 revenue $131M-$142M, consensus $134.65M - TheFly
- 10 days ago - Opko Health sees FY26 revenue $560M-$585M, consensus $536.88M - TheFly
- 10 days ago - Opko Health reports Q2 EPS (1c), one estimate (11c) - TheFly
- 10 days ago - OPKO Health Earnings Call Transcript: Q2 2026 - Transcripts
- 10 days ago - OPKO Health Earnings release: Q2 2026 - Filings
- 10 days ago - OPKO Health Quarterly report: Q2 2026 - Filings